Selective Serotonin Reuptake Inhibitor Discontinuation for Psilocybin Treatment and Contributions to Alcohol Addiction Relapse
A man with AUD achieves sobriety on treatment with an SSRI and naltrexone, but then stops taking the SSRI to participate in a psilocybin “ceremony.” What factors contributed to his subsequent relapse to alcohol use?
Authors
- Mark A. Frye (ORCID: https://orcid.org/0000-0001-6997-4215)
- Tyler Oesterle (ORCID: https://orcid.org/0000-0002-7363-8086)
- Balwinder Singh (ORCID: https://orcid.org/0000-0001-7062-8192)
- Scott Breitinger (ORCID: https://orcid.org/0000-0002-8660-212X)
Institutions
- Mayo Clinic (US)
Publication Details
- Journal
- The Journal of Clinical Psychiatry
- Published
- 2024-08-25
- DOI
- https://doi.org/10.4088/jcp.24cr15378
- Citations
- 2
- Primary Topic
- Psychedelics and Drug Studies
- Type
- article
- Field-Weighted Citation Impact
- 1.28